22.06.2015 • NewsArkemaDowManufacturing

Michelle Williams leading Arkema’s PMMA business unit

Michelle Williams is being appointed Managing Director of Arkema’s PMMA...
Michelle Williams is being appointed Managing Director of Arkema’s PMMA (Altuglas International) business unit effective 1st July 2015.

Michelle Williams is being appointed Managing Director of Arkema’s PMMA (Altuglas International) business unit effective 1st July 2015. Williams holds a PhD in Physical Chemistry from the University of Utah, and completed the Graduate Management program at the University of Pennsylvania.
She began her career in 1987 at Rohm and Haas Company as a Research Scientist. During her career with Rohm and Haas Company and Dow Chemical, Michelle also held manufacturing, sales, marketing, strategy, and general management positions. She was General Manager, CMP Technologies, and later General Manager, Adhesives and Sealants. Michelle joined Arkema in 2011 after a 23 year career at Rohm and Haas and Dow Chemical. In 2011 she was named Global Group President of Arkema’s Hydrogen Peroxide business unit.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read